Biolase, Inc. (BIOL) Social Stream
BIOLASE INC (BIOL) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering BIOLASE INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-18 | 1 | $2 | $2 | $2 | $4.13 | -51.57% |
| 2022-03-22 | 1 | $2.001 | $2 | $2 | $4.13 | -51.57% |
| 2022-04-08 | 1 | $50 | $37.5 | $43.75 | $4.13 | 959.32% |
| 2022-06-03 | 3 | $25 | $10 | $17.5 | $4.13 | 323.73% |
| 2022-11-18 | 3 | $25 | $5 | $15 | $4.13 | 263.2% |
| 2023-04-06 | 1 | $2 | $1 | $1.5 | $4.13 | -63.68% |
| 2023-05-31 | 2 | $2 | $0.4 | $1.133 | $4.13 | -72.57% |
| 2023-06-09 | 2 | $200 | $30 | $90 | $4.13 | 2079.18% |
The Trend in the Analyst Price Target
BIOL's average price target has moved down $1.48 over the prior 37 months.
Over the past 30 weeks, BIOL's average upside potential has been 9,676.67%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-11 | 3 | 25 | 5.0 | 15.000 | 1.640 | 814.63% |
| 2023-03-29 | 2 | 12 | 1.0 | 5.000 | 0.328 | 1424.39% |
| 2023-04-06 | 1 | 12 | 1.0 | 5.000 | 0.280 | 1685.71% |
| 2023-04-06 | 3 | 12 | 1.0 | 5.000 | 0.280 | 1685.71% |
| 2023-05-31 | 2 | 2 | 0.4 | 1.133 | 0.082 | 1281.71% |
BIOL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
BIOL's average broker recommendation rating improved by 0 over the prior 30 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, BIOLASE INC's number of analysts covering the stock is higher than 61.46% of them.
- BIOL has a higher upside potential (average analyst target price relative to current price) than 710.49% of all US stocks.
- BIOL has a lower variance in analysts' estimates than -996.03% of Medical Equipment stocks.
- In terms of how BIOLASE INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 441.92% of that group.
In the Medical Equipment industry, RXST, CHEK, and BBLG are the three stocks most similar to BIOLASE INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is BIOL a Buy, Hold or Sell? See the POWR Ratings now!